Literature DB >> 9325265

The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis.

S S Apte1, N Fukai, D R Beier, B R Olsen.   

Abstract

The matrix metalloproteinases (MMPs) are a family of zinc-containing matrix degrading endopeptidases. A subfamily of membrane type (MT) -MMPs has been described recently. We have determined the structure of the gene (Mmp14) encoding the first MT-MMP to be described, MT1-MMP (MMP-14), and mapped it to mouse chromosome 14. The mouse MMP-14 protein is encoded by ten exons. The novel C-terminal peptide domains of MMP-14 are encoded by a single large exon that also encodes the 3'-untranslated region. The structure of the exons encoding the catalytic domain and pro-domain of MMP-14 is distinct from previously described MMP genes, whereas the exons encoding the hemopexin-like domains are similar to those of most other MMP genes. Mmp14 and the gene for tissue inhibitor of metalloproteinases-2 (Timp2) show a temporally and spatially co-regulated expression during mouse development. They are co-expressed during vascular and urogenital development and during the development of osteocartilaginous and musculotendinous structures. The stringent co-expression of these two genes suggests common regulatory pathways that may have important functional implications for the activation of pro-gelatinase A in health and disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325265     DOI: 10.1074/jbc.272.41.25511

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I.

Authors:  Z Zhou; S S Apte; R Soininen; R Cao; G Y Baaklini; R W Rauser; J Wang; Y Cao; K Tryggvason
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

2.  Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.

Authors:  B Annabi; A Pilorget; N Bousquet-Gagnon; D Gingras; R Béliveau
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

Review 3.  Matrix remodeling during endochondral ossification.

Authors:  Nathalie Ortega; Danielle J Behonick; Zena Werb
Journal:  Trends Cell Biol       Date:  2004-02       Impact factor: 20.808

4.  Biologic augmentation of rotator cuff repair.

Authors:  Scott R Montgomery; Frank A Petrigliano; Seth C Gamradt
Journal:  Curr Rev Musculoskelet Med       Date:  2011-12

Review 5.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

6.  Identification of cis-acting promoter elements that support expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) in v-src transformed Madin-Darby canine kidney cells.

Authors:  H J Cha; A Okada; K W Kim; H Sato; M Seiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell development.

Authors:  Guoxiang Jin; Fengju Zhang; Kui Ming Chan; Hoi Leong Xavier Wong; Baohua Liu; Kathryn S E Cheah; Xinguang Liu; Cornelia Mauch; Depei Liu; Zhongjun Zhou
Journal:  EMBO J       Date:  2011-05-13       Impact factor: 11.598

8.  An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature.

Authors:  Kaisa Lehti; Edward Allen; Henning Birkedal-Hansen; Kenn Holmbeck; Yasuhiro Miyake; Tae-Hwa Chun; Stephen J Weiss
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

9.  Metalloproteases and tendinopathy.

Authors:  Angelo Del Buono; Francesco Oliva; Leonardo Osti; Nicola Maffulli
Journal:  Muscles Ligaments Tendons J       Date:  2013-05-21

10.  Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model.

Authors:  H J Salminen; A-M K Säämänen; M N Vankemmelbeke; P K Auho; M P Perälä; E I Vuorio
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.